These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4136623)

  • 21. [Insomnia and cerebral metabolism of serotonin in cats: study of in vitro synthesis and release of serotonin 18 hours after destruction of the raphe nuclei].
    Pujol JF; Sordet F; Petitjean F; Germain D; Jouvet M
    Brain Res; 1972 Apr; 39(1):137-49. PubMed ID: 4537239
    [No Abstract]   [Full Text] [Related]  

  • 22. The origin of blood 5-hydroxyindoleacetic acid following L-hydrazine-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of gonadal hormones on aromatic amino acid decarboxylase in the rat uterus.
    Snyder SH; Axelrod J; Wurtman RJ
    Endocrinology; 1966 Jun; 78(6):1135-8. PubMed ID: 5296891
    [No Abstract]   [Full Text] [Related]  

  • 24. The origin of blood k-hydroxyindoleacetic acid following L-hydrazino-alpha-methyldopa (MK-486).
    Warsh JJ; Stancer HC
    Eur J Pharmacol; 1975 May; 32(1):128-32. PubMed ID: 1080115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proportionate loss of L-3,4-dihydroxyphenylalanine and L-5-hydroxttryptophan decarboxylating activity in rat central nervous system following intracisternal administration of 5, 6-dihydroxytryptamine or 6-hydroxydopamine.
    Dairman W; Horst WD; Marchelle ME; Bautz G
    J Neurochem; 1975 Apr; 24(4):619-23. PubMed ID: 1079044
    [No Abstract]   [Full Text] [Related]  

  • 26. Parkinson's disease. Modification by 5-hydroxytryptophan.
    Chase TN; Ng LK; Watanabe AM
    Neurology; 1972 May; 22(5):479-84. PubMed ID: 4563493
    [No Abstract]   [Full Text] [Related]  

  • 27. [Norepinephrine and serotonin metabolism in the central nervous system in relation to the rhythm of sleep and wakefulness].
    Matussek N; Schuster I; v Mantey S
    Arzneimittelforschung; 1966 Feb; 16(2):259-61. PubMed ID: 5299189
    [No Abstract]   [Full Text] [Related]  

  • 28. L- -methyl- -hydrazino- -(3,4-dihydroxyphenyl)propionic acid: relative lack of antidecarboxylase activity in adrenals.
    Horita A; Nair X; Hamilton AE
    Science; 1972 May; 176(4037):931-2. PubMed ID: 4537521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in rats.
    Fuller RW; Snoddy HD; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1992 Apr; 76(1):121-4. PubMed ID: 1381513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid.
    Eccleston D; Ashcroft GW; Moir AT; Parker-Rhodes A; Lutz W; O'Mahoney DP
    J Neurochem; 1968 Sep; 15(9):947-57. PubMed ID: 5303059
    [No Abstract]   [Full Text] [Related]  

  • 31. Tryptophan loading: consequent effects on the synthesis of kynurenine and 5-hydroxyindoles in rat brain.
    Gál EM; Young RB; Sherman AD
    J Neurochem; 1978 Jul; 31(1):237-44. PubMed ID: 307593
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
    Vogel WH; Mahoney K; Hare TA
    Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis of serotonin by pineal glands of the rat in organ culture.
    Shein HM; Wurtman RJ; Axelrod J
    Nature; 1967 Feb; 213(5077):730-1. PubMed ID: 5298925
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary 5-hydroxyindoleacetic acid in cases of hypertension before and after therapy with guanethidine and methyldopa.
    Nath K; Agarwal SN; Mittal HS; Singh KN; Saxena S; Pant H
    J Indian Med Assoc; 1972 Apr; 58(7):242-5. PubMed ID: 4537955
    [No Abstract]   [Full Text] [Related]  

  • 35. A possible feed-back mechanism controlling the biosynthesis of 5-hydroxytryptamine.
    Contractor SF; Jeacock MK
    Biochem Pharmacol; 1967 Oct; 16(10):1981-7. PubMed ID: 5299642
    [No Abstract]   [Full Text] [Related]  

  • 36. Behavioral changes of chronic schizophrenic patients given L-5-hydroxytryptophan.
    Wyatt RJ; Vaughan T; Galanter M; Kaplan J; Green R
    Science; 1972 Sep; 177(4054):1124-6. PubMed ID: 4560057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of monoamine metabolism in the central nervous system.
    Carlsson A; Kehr W; Lindqvist M; Magnusson T; Atack CV
    Pharmacol Rev; 1972 Jun; 24(2):371-84. PubMed ID: 4564607
    [No Abstract]   [Full Text] [Related]  

  • 38. 6-hydroxydopamine sympathectomy in the neonatal rat--effects on brain serotonin and histamine.
    Peters DA; Mazurkiewicz-Kwilecki M; Pappas BA
    Biochem Pharmacol; 1974 Sep; 23(17):2395-401. PubMed ID: 4547966
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-Hydroxytryptophan-decarboxylase activity in the decapod crustacean Upogebia littoralis.
    Marmaras VJ; Fragoulis EG
    Experientia; 1970 Apr; 26(4):359-60. PubMed ID: 5309629
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-hydroxyindoles in phenylketonuric and nonphenylketonuric mental defectives.
    Pare CM
    Adv Pharmacol (1962); 1968; 6(Pt B):159-65. PubMed ID: 4232127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.